Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

The FDA will require Moderna and Pfizer to add warnings to their COVID-19 vaccine labels about myocarditis and pericarditis in young men.

In the wake of recent warnings from the Food and Drug Administration (FDA), about half of Americans think vaccines against ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

The shift indicates that critics' efforts to build support by releasing data on the harmful effects of the COVID-19 vaccines ...

The FDA approved Moderna’s new Covid-19 vaccine late Friday, though it placed restrictions on its use that the company’s ...

The agency recommends manufacturers update their vaccines to target the JN.1 strain. At the same time, HHS head Robert F.

The FDA is also expanding its warning that some vaccines are linked to a risk of heart inflammation in young men.

Over the weekend, the FDA issued final approval for a new type of vaccine from Moderna, a next generation shot that allows ...

The shot is also cleared for individuals between 12 and 64 years of age who are at least one risk factor as defined by the ...

The Food and Drug Administration ... also includes an updated warning regarding the increased risk of myocarditis and pericarditis with mRNA COVID-19 vaccines. The mNexspike vaccine is supplied ...